Conestoga Capital Advisors’s Idexx Laboratories IDXX Stock Holding History

Conestoga Capital Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$444K	Sell	790 -415	-34%	-$266K	0.01%	96
2025 Q4	$815K	Sell	1,205 -484	-29%	-$330K	0.01%	89
2025 Q3	$1.08M	Buy	1,689 +5	+0.3%	+$3.04K	0.02%	87
2025 Q2	$903K	Sell	1,684 -10	-0.6%	-$4.78K	0.01%	91
2025 Q1	$711K	Buy	1,694 +70	+4%	+$30.4K	0.01%	101
2024 Q4	$671K	Sell	1,624 -5	-0.3%	-$2.19K	0.01%	100
2024 Q3	$823K	Sell	1,629 -85	-5%	-$41.3K	0.01%	95
2024 Q2	$835K	Sell	1,714 -15	-0.9%	-$7.53K	0.01%	96
2024 Q1	$934K	Buy	1,729 +5	+0.3%	+$2.73K	0.01%	98
2023 Q4	$957K	Sell	1,724 -40	-2%	-$18.8K	0.01%	98
2023 Q3	$771K	Buy	1,764 +285	+19%	+$142K	0.01%	99
2023 Q2	$743K	Sell	1,479 -171	-10%	-$81.9K	0.01%	95
2023 Q1	$825K	Buy	1,650 +70	+4%	+$33.5K	0.01%	98
2022 Q4	$645K	Hold	1,580	–	–	0.01%	105
2022 Q3	$515K	Sell	1,580 -20	-1%	-$7.35K	0.01%	110
2022 Q2	$561K	Sell	1,600 -15	-0.9%	-$6.12K	0.01%	110
2022 Q1	$884K	Buy	1,615 +125	+8%	+$65.8K	0.01%	105
2021 Q4	$981K	Hold	1,490	–	–	0.01%	104
2021 Q3	$927K	Buy	1,490 +20	+1%	+$13.4K	0.01%	106
2021 Q2	$928K	Buy	1,470 +170	+13%	+$93.9K	0.01%	102
2021 Q1	$636K	Hold	1,300	–	–	0.01%	106
2020 Q4	$650K	Sell	1,300 -75	-5%	-$33.6K	0.01%	112
2020 Q3	$541K	Hold	1,375	–	–	0.01%	118
2020 Q2	$454K	Buy	1,375 +100	+8%	+$29K	0.01%	121
2020 Q1	$309K	Sell	1,275 -100	-7%	-$26.1K	0.01%	122
2019 Q4	$359K	Buy	1,375 +75	+6%	+$19.8K	0.01%	129
2019 Q3	$354K	Sell	1,300 -11,035	-89%	-$3.07M	0.01%	115
2019 Q2	$3.4M	Sell	12,335 -4,955	-29%	-$1.22M	0.08%	67
2019 Q1	$3.87M	Buy	17,290 +299	+2%	+$61.7K	0.11%	64
2018 Q4	$3.16M	Buy	16,991 +490	+3%	+$100K	0.1%	67
2018 Q3	$4.12M	Buy	16,501 +3,295	+25%	+$800K	0.11%	59
2018 Q2	$2.88M	Sell	13,206 -260	-2%	-$53.6K	0.09%	60
2018 Q1	$2.58M	Sell	13,466 -445	-3%	-$82.1K	0.1%	58
2017 Q4	$2.17M	Buy	13,911 +2,560	+23%	+$403K	0.08%	62
2017 Q3	$1.76M	Buy	11,351 +6,026	+113%	+$953K	0.08%	67
2017 Q2	$860K	Sell	5,325 -75	-1%	-$12.2K	0.04%	70
2017 Q1	$835K	Buy	5,400 +3,100	+135%	+$427K	0.05%	69
2016 Q4	$270K	Buy	+2,300	New	+$262K	0.02%	98

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Conestoga Capital Advisors's IDXX Position: Q1 2026 in Review

Conestoga Capital Advisors reduced its Idexx Laboratories (IDXX) stake by 34% in Q1 2026, selling an estimated $266K and leaving 790 shares worth $444K. The position accounts for 0.01% of the portfolio, ranked #96.

Conestoga Capital Advisors first reported a position in IDXX in Q4 2016 and has held it in 38 quarters since. The position peaked at $4.12M in Q3 2018. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Conestoga Capital Advisors held 790 shares of Idexx Laboratories worth $444K as of Q1 2026.
Conestoga Capital Advisors sold 415 Idexx Laboratories shares in Q1 2026, an estimated $266K.
Idexx Laboratories made up 0.01% of Conestoga Capital Advisors's portfolio in Q1 2026, its #96 holding.
Conestoga Capital Advisors first reported a position in Idexx Laboratories in Q4 2016 and has held it in 38 quarters since.
Conestoga Capital Advisors's Idexx Laboratories position peaked at $4.12M in Q3 2018.
1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Conestoga Capital Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.